Skip to main content
Fig. 2 | Journal of Experimental & Clinical Cancer Research

Fig. 2

From: A novel ETV6-miR-429-CRKL regulatory circuitry contributes to aggressiveness of hepatocellular carcinoma

Fig. 2

The expression patterns of CRKL in hepatocarcinoma patients’ tumorous tissues and HCC cells. a WB measured the protein expression level of CRKL in hepatocarcinoma patients’ tumorous tissues and corresponding non-tumor liver tissues. CRKL was overexpressed in hepatocarcinoma patients’ tumorous tissues. b WB measured the protein expression level of ETV6 in HCC HepG2, HCCLM3 HuH7 cells and human normal liver LO2 cells. CRKL was overexpressed in HCC cells. c IHC measured the protein expression level of CRKL in 48 paired tumorous and adjacent normal tissues from HCC patients

Back to article page